Charles Berkman
Director/Board Member at VERNALIS
Net worth: 1 M $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Matthew Foehr | M | 51 |
Ligand UK Research Ltd.
 Ligand UK Research Ltd. Pharmaceuticals: MajorHealth Technology Part of Ligand Pharmaceuticals, Inc., Ligand UK Research Ltd. develops pharmaceutical products. The company is based in London, UK. Founded in 1995.
Ligand UK Group Ltd.
 Ligand UK Group Ltd. Financial ConglomeratesFinance Founded in 1995, Ligand UK Group Ltd. is a subsidiary of Ligand Pharmaceuticals, Inc. and functions as an investment holding company. The company is based in Cambridge, UK.
OmniAb Operations, Inc.
 OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | 13 years |
| John Higgins | M | 54 |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA.
Metabasis Therapeutics, Inc.
 Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | 17 years |
| Matthew Korenberg | M | 49 |
Ligand UK Group Ltd.
Ligand UK Group Ltd. Financial ConglomeratesFinance Founded in 1995, Ligand UK Group Ltd. is a subsidiary of Ligand Pharmaceuticals, Inc. and functions as an investment holding company. The company is based in Cambridge, UK.
Ligand UK Research Ltd.
Ligand UK Research Ltd. Pharmaceuticals: MajorHealth Technology Part of Ligand Pharmaceuticals, Inc., Ligand UK Research Ltd. develops pharmaceutical products. The company is based in London, UK. Founded in 1995. | 9 years |
| Sarah Boyce | F | 52 |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | 5 years |
| Jennifer Cochran | M | 52 |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | 2 years |
| Carolyn Bertozzi | M | 57 |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | 2 years |
| Todd Davis | M | 63 | 17 years | |
| Joshua Tamaroff | M | 38 |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | 2 years |
| Octavio Espinoza | M | 53 | 2 years | |
| Marie-Cecile van de Lavoir | M | - |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | - |
| Jason Haas | M | 56 | 2 years | |
| Eric Vajda | M | - | 21 years | |
| Nancy Gray | M | 64 | 7 years | |
| Sandford Sommer | M | - | 8 years | |
| Todd Pettingill | M | - |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | - |
| Andrew Reardon | M | 49 | 2 years | |
| John Kozarich | M | 74 | 21 years | |
| Jason Aryeh | M | 56 | 18 years | |
| Stephen Sabba | M | 64 | 16 years | |
| Kurt Gustafson | M | 56 |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | 2 years |
| Steven Love | M | 55 | 1 years | |
| John LaMattina | M | 74 | 13 years | |
| John P. Sharp | M | 59 |
Metabasis Therapeutics, Inc.
Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | 17 years |
| Keith Haney | M | - | 10 years | |
| Christoper Silvia | M | - | - | |
| Donna Ventura | F | - | 2 years | |
| Jason Michael Atticus Grenfell-Gardner | M | 50 | - | |
| Mike Wood | M | - | 20 years | |
| Greg Blank | M | - | - | |
| David A. Bullough | M | - |
Metabasis Therapeutics, Inc.
Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | 27 years |
| Timothy Cowper | M | - | - | |
| Cia McCaffrey | F | - | - | |
| Benjamin Silbert | M | 54 | - | |
| Molly A. Holman | M | - |
Metabasis Therapeutics, Inc.
Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | 16 years |
| Diane Retallack | F | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Patrick Lucy | M | 56 | 11 years | |
| Evert Schimmelpennink | M | 52 | 3 years | |
| Sunil Patel | M | 52 | 1 years | |
| Paul Laikind | M | 68 |
Metabasis Therapeutics, Inc.
Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | 13 years |
| Phillip Schneider | M | 67 | 6 years | |
| Carol C. Ferguson | F | 77 | 15 years | |
| Lorianne K. Masuoka | M | 62 | 1 years | |
| John M. Taylor | M | 59 | 5 years | |
| Nishan de Silva | M | 51 | 3 years | |
| Magda Marquet | M | 65 | 1 years | |
| Robin D. Campbell | M | 69 | 6 years | |
| David Knott | M | 79 | - | |
| Jason Grenfell-Gardner | M | 49 | 3 years | |
| Ian Garland | M | 59 | 10 years | |
| Melanie J. Herman | F | 45 | 5 years | |
| Warner R. Broaddus | M | - | 6 years | |
| David Eric Robinson | M | - | - | |
| Zofia E. Dziewanowska | M | 82 | 7 years | |
| Peter John Fellner | M | 80 | 15 years | |
| Michael S. Novins | M | - |
Baker & McKenzie LLP (Illinois)
 Baker & McKenzie LLP (Illinois) Miscellaneous Commercial ServicesCommercial Services Baker & McKenzie LLP provides legal services. The company was founded in 1949 and is headquartered in Chicago, IL. | 7 years |
| Richard Ghalie | M | 66 | 4 years | |
| Menashe R. Frank | M | 57 |
Baker & McKenzie LLP (Illinois)
Baker & McKenzie LLP (Illinois) Miscellaneous Commercial ServicesCommercial Services Baker & McKenzie LLP provides legal services. The company was founded in 1949 and is headquartered in Chicago, IL. | 1 years |
| Elizabeth Stoner | M | 73 |
Metabasis Therapeutics, Inc.
Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | 1 years |
| Shawn A. Scranton | M | 60 | 2 years | |
| David C. Furlano | M | - | 5 years | |
| Raymond Chang | M | 53 |
Baker & McKenzie LLP (Illinois)
Baker & McKenzie LLP (Illinois) Miscellaneous Commercial ServicesCommercial Services Baker & McKenzie LLP provides legal services. The company was founded in 1949 and is headquartered in Chicago, IL. | 4 years |
| Richard Warburg | M | - |
Lyon & Lyon, Inc.
 Lyon & Lyon, Inc. Miscellaneous Commercial ServicesCommercial Services Lyon & Lyon, Inc. engages in the provision of legal services. The company was founded on September 4, 1979 and is headquartered in San Diego, CA. | 10 years |
| Susan Jean Wallcraft | F | 58 | 1 years | |
| Filippo Corsi | M | 48 |
Baker & McKenzie LLP (Illinois)
Baker & McKenzie LLP (Illinois) Miscellaneous Commercial ServicesCommercial Services Baker & McKenzie LLP provides legal services. The company was founded in 1949 and is headquartered in Chicago, IL. | 1 years |
| Glenn Dourado | M | - | - | |
| Martin Brenner | M | 54 | 1 years | |
| Jeffrey Miner | M | - | 14 years | |
| Keith E. Anderson | M | 55 | 7 years | |
| Daniel Loeb | M | 62 | 2 years | |
| Jeffrey R. Perry | M | 65 | 4 years | |
| Jessica Stone Rampton | F | 53 | 5 years | |
| James J. L'Italien | M | 71 | 5 years | |
| Andres F. Negro-Vilar | M | - | 11 years | |
| Tod G. Mertes | M | 59 | 6 years | |
| Martin D. Meglasson | M | 74 | 6 years | |
| Mark E. Erwin | M | 59 | 2 years | |
| Brian Lundstrom | M | 61 | 9 years | |
| Steven J. Burakoff | M | 81 | 2 years | |
| Clarke Neumann | M | 60 |
Lyon & Lyon, Inc.
Lyon & Lyon, Inc. Miscellaneous Commercial ServicesCommercial Services Lyon & Lyon, Inc. engages in the provision of legal services. The company was founded on September 4, 1979 and is headquartered in San Diego, CA. | 6 years |
| Richard C. Yocum | M | 68 | 7 years | |
| Brigette Roberts | M | - | 2 years | |
| Maria Bedoya-Toro Munera | M | 72 | 3 years | |
| Syed M. J. Kazmi | M | 67 | 17 years | |
| William R. Rohn | M | 80 |
Metabasis Therapeutics, Inc.
Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | 6 years |
| Bruce Peacock | M | 72 | 1 years | |
| Elizabeth M. Greetham | F | 74 | 1 years | |
| Michael Rocca | M | 79 | 8 years | |
| Alexander D. Cross | M | 91 | - | |
| John Groom George | M | - | 12 years | |
| Irving S. Johnson | M | - | 18 years | |
| Carl C. Peck | M | - | 10 years | |
| Paul Maier | M | 76 | 15 years | |
| Arnold Lewis Oronsky | M | 83 |
Metabasis Therapeutics, Inc.
Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | 10 years |
| George F. Schreiner | M | 74 |
Metabasis Therapeutics, Inc.
Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | 3 years |
| Thomas H. Silberg | M | 76 | 3 years | |
| Daniel Burgess | M | 62 |
Metabasis Therapeutics, Inc.
Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | 6 years |
| Taylor J. Crouch | M | 64 | 2 years | |
| Simon Latimer | M | - | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 91 | 92.86% |
| United Kingdom | 9 | 9.18% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Charles Berkman
- Personal Network